CareDx, Inc (NASDAQ:CDNA) Receives Consensus Rating of “Moderate Buy” from Brokerages

CareDx, Inc (NASDAQ:CDNA – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month target price among analysts […]

Leave a Reply

Your email address will not be published.

Previous post Mercer International Inc. (NASDAQ:MERC) Receives $8.67 Consensus PT from Analysts
Next post Trisura Group Ltd. (TSE:TSU) Receives Average Rating of “Buy” from Brokerages